Takahashi et al.22 found that CD31+ EMVs, CD62E+ EMVs and CD144+ EMVs were significantly increased in stable COPD patients and during exacerbation compared with healthy control subjects; meanwhile, circulating CD146+ EMVs were not increased in stable COPD patients or during exacerbation. This evidence concerns the gene MCAM and chronic obstructive pulmonary disease.